Sep 21 2020 21 mins 127
Join Dan McCollum and EM clinical pharmacist RJ LaCoursiere as they discuss the use of buprenorphine for the treatment of Opioid Use Disorder.
- Who should be considered for treatment with Medication-Assisted Treatment (MAT)?
- Why should it be avoided if the patient isn't in acute withdrawal?
- What is a DEA X waiver and why should you look into getting waivered?
- How can we reduce stigma for these patients?
Free training can be found at https://nhsc.hrsa.gov/loan-repayment/receive-medication-assisted-treatment-training .
This podcast will be cross published with the Pharm So Hard podcast, so check them out for additional pharmacology pearls.
A special thanks to student doctor Michael Stephens for editing this podcast.
